MedDRA - 10015560 MedDRA - 10015759 MedDRA - 10057846 (Primitiver neuroextodermaler Tumor) C40 C41
Conditions
Interventions
Group 1: Data will be collected for all newly diagnosed patients with localized or metastatic EwS that cannot be included in ongoing clinical trials. Patients from clinical trials can also be included
Sponsors
Universitätsklinikum Essen, Zentrum für Kinder- und Jugendmedizin, Klinik für Kinderheilkunde III, Ewing-Studienzentrale
Eligibility
Sex/Gender
All
Age
0 Years to 99 Years
Inclusion criteria
Inclusion criteria: Primary diagnosed and histologically confirmed, localised or metastatic Ewing sarcoma or Ewing-like sarcoma or adult DSRCT of bone or soft tissue.
Exclusion criteria
Exclusion criteria: No Informed Consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major Objectives: - To collect long-term follow-up data that exceeds current clinical studies - To collect data from patients receiving standard treatment when no current clinical study is available - To collect data from patients not fulfilling other clinical study criteria - To collect biomaterial for ancillary studies | — |
Secondary
| Measure | Time frame |
|---|---|
| not applicable, registry | — |
Countries
Austria, Czechia, Germany, Poland, Sweden
Contacts
Public ContactUta Dirksen
Universitätsklinikum Essen, Zentrum für Kinder- und Jugendmedizin, Klinik für Kinderheilkunde III, Ewing-Studienzentrale
Outcome results
None listed